RIÑÓN Y ENFERMEDAD CARDIOVASCULAR - Seden

BIBLIOGRAFÍA
1538. Abbot KC, Hishieh P, Cruess D, Agodoa LY, Welch PG, Taylor
AJ y cols. Hospitalized valvular heart disease in patients in
renal transplant waiting list: incidence, clinical correlates
and outcomes. Clin Nephrol 59:79-87, 2003.
1539. Le A, Wilson R, Douek K, Pulliam L, Tolzman D, Norman D
y cols. Prospective risk stratification in renal transplant candidates
for cardiac death. Am J Kidney Dis 24:65-71,1994.
1540. Lewis MS, Wilson RA, Walker KW, Wilson DJ, Norman DJ,
Barry JM y cols. Validation of an algorithm for predicting cardiac
events in renal transplant candidates. Am J Cardiol
89:847-850, 2002.
1541. De Lima JJ, Sabbaga E, Vieira ML, de Paula FJ, Ianhez LE,
Krieger EM y cols. Coronary angiography is the best predictor
of events in renal transplant candidates compared with
non-invasive testing. Hypertension 42:263-8, 2003.
1542. Koch MGF, Gradaus F, Schoebel FC, Leschke M, Grabensee
B. Relevance of conventional cardiovascular risk factors for
the prediction of coronary artery disease in diabetic patients
on renal replacement therapy. Nephrol Dial Transplant
12:1187-91, 1997.
1543. Fredericks S, Chang R, Gregson H, Bewick M, Collinson PO,
Gaze D y cols. Circulating cardiac troponin-T in patients
before and after renal transplantation. Clin Chim Acta
310:199-203, 2001
1544. Goldsmith DJA and Covic A. Coronary artery disease in uremia:
etiology, diagnosis and therapy. Kidney Int 60: 2059-78,
2001.
1545. Logar CM, Herzog CA and Beddhu S. Diagnosis and therapy
of coronary artery disease in renal failure, end-stage renal
disease, and renal transplant populations. Am J Med Sci 325:
214-27, 2003.
1546. Roppolo LP, Fitzgerald R, Dillow J, Ziegler T, Rice M, Maisel
A. A comparison of troponin T and troponin I as predictors
of acardiac events in aptients undergoing chronic dialysis at
a Veteran´s Hospital: a pilot study. J Am Coll Cardiol 34: 448-
54, 1999.
1547. Serruys PW, Unger F, Sousa JE, Jatene A, Bonnier HJ,
Schonberger JP y cols. Comparison of coronary-artery
bypass surgery and stenting for the treatment of multivessel
disease. N Engl J Med 334 (15): 1117-24, 2001.
1548. Haller C. Percutaneous coronary interventions in patients
with renal failure: overcoming in-stent restenosis? Nephrol
Dial Transplant 17: 401-3, 2002.
1549. Herzog CA, Ma JZ and Collins AJ. Long-term outcome of
renal transplant recipients in the United States after coronary
revascularization procedures. Circulation 109: 2866-71,
2004.
1550. Kasiske BL, Chakkera HA, Louis TA and Ma JZ. A meta-analysis
of inmunosupresión withdrawal trials in renal transplantation.
J Am Soc Nephrol 11: 1910-7, 2000.
1551. Australian New Zealand Dialysis, Transplant registry (ANZ-
DATA). ANZATA Report. January 2002.
1552. Mange KC, Cizman B, Joffe M and Feldman HI. Arterial
hypertension and renal allograft survival. JAMA 283: 633-8,
2000.
1553. Kasiske BL, Anjum S, Shah R, Skogen J, Kandaswamy C,
Danielson B y cols. Hypertension after kidney transplantation.
Am J Kidney Dis 43: 1071-81, 2004.
1554. Opelz G, Wujciak T, Ritz E for the Collaborative Transplant
Study: Association of chronic kidney graft failure with recipient
blood pressure. Kidney Int 53: 217-222, 1998.
1555. K/DOQUI.Guideline1: goals of antihypertensive therapy in
CKD. Am J Kid Dis 43: S65-S73, 2004.
1556. Zayas CF, Guasch A. Early glomerular dysfunction in human
renal allografts. Kidney Int 60:1938-1947,2001.
1557. Curtis JJ, Luke RG, Jones P, Diethelm AG. Hypertension in
cyclosporine-treated renal transplant recipients is sodium
dependent. Am J Med 85:134-138,1988.
1558. Branten AJW, Hilbrands LB, Van Hamersvelt HW, Koene RAP
and Huysmans FTM. Renal and systemic effects of atenolol
and tertatolol in renal transplant recipients on cyclosporine
A. Nephrol Dial Transplant 13: 423-6, 1998.
1559. Midtvedt K, Hartmann A, Holdaas H and Fauchald P. Efficacy
of nifedipine or lisinopril in the treatment of hypertension
after renal transplantation: a double-blind randomised comparative
trial. Clin Transplant 15: 426-31, 2001.
1560. Srinivas TR, Meier-Kriesche HU, Kaplan B, Bennet WM.
Sustained improvement of renal graft function for two years
in hypertensive renal transplant recipients treated with nifedipine
compared with lisinopril. Transplantation 15:1787-
92,2001.
1561. Venkat Raman G, Feehally J, Coates RA, Elliott HL, Griffin PJ,
Olubodun JO y cols. Renal effects of amlodipine in normotensive
renal transplant recipients. Nephrol Dial Transplant
14: 384 -8, 1999.
1562. Rump LC, Oberhauser V, Schwertfeger E, Speidel L,
Zimmerhackl L, Kirste G, y cols. Dihydropyridine calcium
antagonists and renal function in hypertensive kidney transplant
recipients. J Hypertens 18: 1115-9, 2000.
1563. Chanard J, Toupance O, Lavaud S, Hurault de Ligny B,
Bernaud C, Moulin B y cols. Amlodipine reduces cyclosporine-induced
hyperuricemia in hypertensive renal transplant
recipients. Nephrol Dial Transplant 18: 2147-53, 2003.
1564. Iñigo P, Campistol JM, Lario S, Piera C, Campos B, Bescos M,
y cols. Effects of losartan and amlodipine on intrarrenal
hemodynamics and TGF-_1 plasma levels in a crossover trial
in renal transplant recipients. J Am Soc Nephrol 12: 822-7,
2001.
1565. Martinez-Castelao A, Hueso M, Sanz V, Rejas J, Alsina J,
Grinyo JM. Treatment of hypertension after renal transplantation:
long-term efficacy of verapamil, enalapril and doxazosin.
Kidney Int 54: 130-4, 1998.
1566. Sennesael J, Lamote J, Violet I, Tasse S, Verbeelen D.
Comparison of perindopril and amlodipine in cyclosporinetreated
renal allograft recipients. Hypertension 26: 436-44,
1995.
1567. Asberg A, Midtvedt K, Vassbotn T and Hartmann A. Better
microvascular function on long-term treatment with lisinopril
than with nifedipine in renal transplant recipients.
Nephrol Dial Transplant 16: 1465-70, 2001.
1568. Suwelack B, Kobelt V, Erfmann M, Hausberg M, Gerhardt U,
Rahn KH y cols. Long-term follow-up of ACE-inhibitor verusus
beta-blocker treatment and their effects on blood pressure
and kidney function in renal transplant recipients. Transpl
Int 16: 313-20, 2003.
1569. Stigart CE, Cohen J, Vivero M, Zoltzman JS. ACE inhibitors
and angiotensin II antagonists in renal transplantation : An
analysis of safety and efficacy. Am J Kidney Dis 35:58-
63,2000.
1570. Holgado R, Anaya F and Del Castillo D. Angiotensin II type
1 (AT1) receptor antagonists in the treatment of hypertension
after renal transplantation. Nephrol Dial Transplant 16
(Suppl 1): 117-20, 2001.
234